Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biosion, Gannex, Junshi.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Brii, Daiichi Sankyo, Pfizer, SCG, Tevogen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, HLB, I-Mab, Inmexd, Innovent, Neuren, Onconic, Opthea, Otsuka, Rege, Telix, Tyligand,

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Cynata, Experion, Innocare, Remegen, Telix, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hutchmed, Innocare, Immutep, Recce, Sumitomo.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acepodia, Adcentrx, Alterity, FDS, Incannex, Innovent, Neushen, Tiumbio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bio-gene, Foresee, Hanall, Immutep, Recce.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen, Atom, Caliway, Immutep, Lisata, Recce.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen, Imugen, Taigen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Akeso, Henlius, Imugene, Kexing, Transthera.